Log In
BCIQ
Print this Print this
 

DLYE5953A, RG7841

  Manage Alerts
Collapse Summary General Information
Company Genentech Inc.
DescriptionAntibody-drug conjugate targeting lymphocyte antigen 6 complex locus E (Ly6E)
Molecular Target Lymphocyte antigen 6 complex locus E (Ly6E)
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat refractory solid tumors; Treat solid tumors
Regulatory Designation
PartnerRoche

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today